Utility of untimed urinary albumin measurements in assessing albuminuria in black NIDDM subjects

被引:35
作者
Chaiken, RL
Khawaja, R
Bard, M
EckertNorton, M
Banerji, MA
Lebovitz, HE
机构
[1] State University of New York, Health Science Center at Brooklyn, Brooklyn, NY
[2] Box 123, State University of New York, Health Science Center at Brooklyn, Brooklyn, NY 11203
关键词
D O I
10.2337/diacare.20.5.709
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To determine the usefulness of an untimed morning urine specimen in screening a black NIDDM population attending an urban diabetes clinic for microalbuminuria. RESEARCH DESIGN AND METHODS - Untimed morning specimens were provided by 218 black NIDDM subjects. Of the 218 subjects, 123 also provided 24-h urine specimens. The 24-h specimens were assayed for albumin excretion rate (AER) in milligrams per 24 h, and the albumin-to-creatinine ratio (A-to-C) in micrograms per milligram was determined on the untimed morning urine specimen. RESULTS - Correlation between the A-to-C ratio and the 24-h AER was 0.96 (P = 0.0001). In the range of clinical proteinuria, r was 0.92 (P = 0.003, n = 7). In the range of microalbuminuria, r was 0.55 (P = 0.005, n = 26), and in the normal range, r was 0.59 (P less than or equal to 0.0001, n = 90). Analysis of the untimed urine specimens from 218 black NIDDM subjects showed that 171 had A-to-C <30 mu g/mg, 38 had A-to-C 30-300 mu g/mg, and 9 had A-to-C >300 mu g/mg. Data were grouped according to duration of NIDDM and the presence or absence of hypertension. None of the newly diagnosed NIDDM patients (<1 year) (n = 40) had microalbuminuria. The frequency of microalbuminuria and clinical proteinuria increased with 1) duration of NIDDM 5-10 years (odds ratio [OR], 3.39; 95% CI 1.17-9.82), 2) duration of NIDDM >10 years (OR, 11.03; 95% CI 4.16-29.25), and 3) presence of hypertension (OR, 2.59; 95% CI 1.20-5.61). CONCLUSIONS - The A-to-C ratio obtained from an untimed morning urine specimen correlates with the AER from a 24-h collection. In black subjects with newly diagnosed NIDDM, microalbuminuria is not present to a significant degree. Duration of NIDDM >5 years is associated with increased prevalence of microalbuminuria, and hypertension is associated with microalbuminuria and clinical proteinuria in this population.
引用
收藏
页码:709 / 713
页数:5
相关论文
共 26 条
[1]  
American Diabetes Association, 1995, DIABETES CARE, V18, P8
[2]  
BENNETT PH, 1995, AM J KIDNEY DIS, V25, P107
[3]  
BERGLUND J, 1987, ACTA MED SCAND, V222, P333
[4]   INTERACTION OF HYPERTENSION AND DIABETES ON RENAL-FUNCTION IN BLACK NIDDM SUBJECTS [J].
CHAIKEN, RL ;
PALMISANO, J ;
NORTON, ME ;
BANERJI, MA ;
BARD, M ;
SACHIMECHI, I ;
BEHZADI, H ;
LEBOVITZ, HE .
KIDNEY INTERNATIONAL, 1995, 47 (06) :1697-1702
[5]   DISPARITIES IN INCIDENCE OF DIABETIC END-STAGE RENAL-DISEASE ACCORDING TO RACE AND TYPE OF DIABETES [J].
COWIE, CC ;
PORT, FK ;
WOLFE, RA ;
SAVAGE, PJ ;
MOLL, PP ;
HAWTHORNE, VM .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (16) :1074-1079
[6]   INCIPIENT AND OVERT DIABETIC NEPHROPATHY IN AFRICAN-AMERICANS WITH NIDDM [J].
DASMAHAPATRA, A ;
BALE, A ;
RAGHUWANSHI, MP ;
REDDI, A ;
BYRNE, W ;
SUAREZ, S ;
NASH, F ;
VARAGIANNIS, E ;
SKURNICK, JH .
DIABETES CARE, 1994, 17 (04) :297-304
[7]  
Diabet Control Complications DCCT Res Grp, 1995, KIDNEY INT, V47, P1703
[8]   ALBUMINURIA AND POOR GLYCEMIC CONTROL PREDICT MORTALITY IN NIDDM [J].
GALL, MA ;
BORCHJOHNSEN, K ;
HOUGAARD, P ;
NIELSEN, FS ;
PARVING, HH .
DIABETES, 1995, 44 (11) :1303-1309
[9]   PREVALENCE OF MICROALBUMINURIA AND MACROALBUMINURIA, ARTERIAL-HYPERTENSION, RETINOPATHY AND LARGE VESSEL DISEASE IN EUROPEAN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS [J].
GALL, MA ;
ROSSING, P ;
SKOTT, P ;
DAMSBO, P ;
VAAG, A ;
BECH, K ;
DEJGAARD, A ;
LAURITZEN, M ;
LAURITZEN, E ;
HOUGAARD, P ;
BECKNIELSEN, H ;
PARVING, HH .
DIABETOLOGIA, 1991, 34 (09) :655-661
[10]   DIABETES IN URBAN AFRICAN-AMERICANS .2. HIGH PREVALENCE OF MICROALBUMINURIA AND NEPHROPATHY IN AFRICAN-AMERICANS WITH DIABETES [J].
GOLDSCHMID, MG ;
DOMIN, WS ;
ZIEMER, DC ;
GALLINA, DL ;
PHILLIPS, LS .
DIABETES CARE, 1995, 18 (07) :955-961